Pillar Biosciences: Eric Lai

Pillar Biosciences has added Eric Lai to its board of directors.

Lai brings more than 20 years of experience in drug and in vitro diagnostic development. He was previously senior VP of genomic medicine at Takeda Pharmaceutical. He also held executive roles at Gen-Prob and GlaxoSmithKline.

Lai holds a doctorate in pharmacology from Columbia University.